The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Tumor Regression Grading After Preoperative Chemoradiotherapy for Locally Advanced Rectal Carcinoma Revisited: Updated Results of the CAO/ARO/AIO-94 Trial
Abstract
Purpose: We previously described the prognostic impact of tumor regression grading (TRG) on the outcome of patients with rectal carcinoma treated with preoperative chemoradiotherapy (CRT) in the CAO/ARO/AIO-94 trial. Here we report long-term results after a median follow-up of 132 months. Patients and Methods: TRG after preoperative CRT was determined in 386 surgical specimens by the amount of viable tumor cells versus fibrosis, ranging from TRG 4 (no viable tumor cells) to TRG 0 (no signs of regression). Clinicopathologic parameters and TRG were correlated to the cumulative incidence of local recurrence, distant metastasis, and disease-free survival (DFS). Results: Ten-year cumulative incidence of distant metastasis and DFS were 10.5% and 89.5% for patients with TRG 4 (complete regression), 29.3% and 73.6% for TRG 2 and 3 (intermediate regression), and 39.6% and 63% for TRG 0 and 1 (poor regression), respectively (P = .005 and P = .008, respectively). On multivariable analysis, residual lymph node metastasis (ypN+) and TRG were the only independent prognostic factors for cumulative incidence of distant metastasis (P < .001 and P = .035, respectively) and DFS (P < .001 and P = .039, respectively), whereas local recurrence was significantly affected by ypN status (P < .001) and lymphatic invasion (P = .026). Conclusion: Complete and intermediate tumor regressions were associated with improved long-term outcome in patients with rectal carcinoma after preoperative CRT independent of clinicopathologic parameters. This classification system needs to be prospectively tested in multiple data sets to validate its reproducibility in a wider setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040694 · Cited by 6,050
Self-citationSauer, R., Liersch, T., Merkel, S., Fietkau, R., Hohenberger, W., Hess, C., Becker, H., Raab, H.-R., Villanueva, M.-T., Witzigmann, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.1836 · Cited by 2,095
Self-citationMandard, A.-M., Dalibard, F., Mandard, J.-C., Marnay, J., Henry-Amar, M., Petiot, J.-F., Roussel, A., Jacob, J.-H., Segol, P., Samama, G., et al. (1994) · Cancer · doi:10.1002/1097-0142(19940601)73:11<2680::aid-cncr2820731105>3.0.co;2-c · Cited by 2,044
Maas, M., Nelemans, P. J., Valentini, V., Das, P., Rödel, C., Kuo, L.-J., Calvo, F. A., García-Aguilar, J., Glynne-Jones, R., Haustermans, K., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70172-8 · Cited by 1,945
Self-citationRAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902
The impact of O2 availability on human cancer
Bertout, J. A., Patel, S. A., & Simon, M. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2540 · Cited by 1,365
Pathological features of rectal cancer after preoperative radiochemotherapy
Dworak, O., Keilholz, L., & Hoffmann, A. (1997) · International Journal of Colorectal Disease · doi:10.1007/s003840050072 · Cited by 1,338
Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer
Rödel, C., Martus, P., Papadoupolos, T., Füzesi, L., Klimpfinger, M., Fietkau, R., Liersch, T., Hohenberger, W., Raab, R., Sauer, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.1329 · Cited by 1,215
Self-citationParallel progression of primary tumours and metastases
Klein, C. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2627 · Cited by 1,133
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
Formenti, S. C., & Demaria, S. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs629 · Cited by 1,053
Oxygen Sensing, Homeostasis, and Disease
Semenza, G. L. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011165 · Cited by 993
Tumor microenvironmental physiology and its implications for radiation oncology
Vaupel, P. (2004) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.04.008 · Cited by 947
Francois, Y., Nemoz, C. J., Baulieux, J., Vignal, J., Grandjean, J.-P., Partensky, C., Souquet, J. C., Adeleine, P., & Gerard, J.-P. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2396 · Cited by 815 · cited 1×
“Various factors seem to determine pathologic tumor regression, including radiotherapy dose and schedule, time between preoperative CRT and surgery, and combination with chemotherapy.(25-28) In this study, we analyzed the prognostic impact of TRG”
BackgroundRödel, C., Liersch, T., Becker, H., Fietkau, R., Hohenberger, W., Hothorn, T., Graeven, U., Arnold, D., Lang-Welzenbach, M., Raab, H.-R., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70187-0 · Cited by 696
Self-citationKurrey, N. K., Jalgaonkar, S. P., Joglekar, A. V., Ghanate, A. D., Chaskar, P. D., Doiphode, R. Y., & Bapat, S. A. (2009) · Stem Cells · doi:10.1002/stem.154 · Cited by 655
Washington, M. K., Berlin, J., Branton, P., Burgart, L. J., Carter, D. K., Fitzgibbons, P. L., Halling, K., Frankel, W., Jessup, J., Kakar, S., et al. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.10.1539 · Cited by 529
Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer
Park, I. J., You, Y. N., Agarwal, A., Skibber, J. M., Rodriguez-Bigas, M. A., Eng, C., Feig, B. W., Das, P., Krishnan, S., Crane, C. H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7901 · Cited by 485
Janjan, N. A., Khoo, V. S., Abbruzzese, J., Pazdur, R., Dubrow, R., Cleary, K. R., Allen, P. K., Lynch, P. M., Glober, G., Wolff, R., et al. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00099-1 · Cited by 458
Collette, L., Bosset, J.-F., den Dulk, M., Nguyen, F., Mineur, L., Maingon, P., Radosevic-Jelic, L., Piérart, M., & Calais, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.9685 · Cited by 447
Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
Kang, Y., & Pantel, K. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.017 · Cited by 421
Epithelial-Mesenchymal Transition and Cell Cooperativity in Metastasis
Tsuji, T., Ibaragi, S., & Hu, G.-F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1618 · Cited by 413
Valentini, V., Coco, C., Picciocchi, A., Morganti, A. G., Trodella, L., Ciabattoni, A., Cellini, F., Barbaro, B., Cogliandolo, S., Nuzzo, G., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02764-5 · Cited by 320
Clinical implications of cancer self-seeding
Comen, E., Norton, L., & Massagué, J. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.64 · Cited by 312
Rödel, F., Hoffmann, J., Distel, L., Herrmann, M., Noisternig, T., Papadopoulos, T., Sauer, R., & Rödel, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3028 · Cited by 292
Self-citationMehrotra, S., Languino, L. R., Raskett, C. M., Mercurio, A. M., Dohi, T., & Altieri, D. C. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.021 · Cited by 291
Quah, H., Chou, J. F., Gonen, M., Shia, J., Schrag, D., Saltz, L. B., Goodman, K. A., Minsky, B. D., Wong, W. D., & Weiser, M. R. (2008) · Cancer · doi:10.1002/cncr.23516 · Cited by 258
Wheeler, J. M. D., Warren, B. F., Mortensen, N. J. M., Ekanyaka, N., Kulacoglu, H., Jones, A. C., George, B. D., & Kettlewell, M. G. W. (2002) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-6359-x · Cited by 186
Mohiuddin, M., Regine, W. F., John, W. J., Hagihara, P. F., McGrath, P. C., Kenady, D. E., & Marks, G. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00486-1 · Cited by 185
Stipa, F., Chessin, D. B., Shia, J., Paty, P. B., Weiser, M., Temple, L. K. F., Minsky, B. D., Wong, W. D., & Guillem, J. G. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.03.053 · Cited by 173
Mohiuddin, M., Hayne, M., Regine, W. F., Hanna, N., Hagihara, P. F., McGrath, P., & Marks, G. M. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00732-x · Cited by 170
Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer
McCarthy, K., Pearson, K., Fulton, R., & Hewitt, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008368.pub2 · Cited by 169
Kuo, L.-J., Liu, M.-C., Jian, J. J.-M., Horng, C.-F., Cheng, T.-I., Chen, C.-M., Fang, W.-T., & Chung, Y.-L. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9471-z · Cited by 169
The RAS signal transduction pathway and its role in radiation sensitivity
McKenna, W. G., Muschel, R. J., Gupta, A., Hahn, S. M., & Bernhard, E. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206699 · Cited by 149
Wolthuis, A. M., PENNINCKX, F. M., Haustermans, K. M., Hertogh, G. D., Fieuws, S., Cutsem, E. V., & D’Hoore, A. J. L. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2327-1 · Cited by 141
Suárez, J., Vera, R., Balén, E. M., Gómez, M., Arias, F., Lera, J. M., Herrera, J. J., & Zazpe, C. (2007) · Colorectal Disease · doi:10.1111/j.1463-1318.2007.01424.x · Cited by 125
Bonnetain, F., Bosset, J. F., Gérard, J., Calais, G., Conroy, T., Mineur, L., Bouché, O., Maingon, P., Chapet, O., Radošević-Jelić, L., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.03.016 · Cited by 112
Das, P., Lin, E. H., Bhatia, S., Skibber, J. M., Rodrı́guez-Bigas, M. A., Feig, B. W., Chang, G. J., Hoff, P. M., Eng, C., Wolff, R. A., et al. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.07.1374 · Cited by 82
The Role of Survivin for Radiation Therapy: Prognostic and Predictive Factor and Therapeutic Target
Capalbo, G., Rödel, C. M., Stauber, R. H., Knauer, S. K., Bache, M., Kappler, M., & Rödel, F. (2007) · Strahlentherapie und Onkologie · doi:10.1007/s00066-007-1800-4 · Cited by 80
Self-citationShivnani, A. T., Small, W. C., Stryker, S. J., Kiel, K. D., Lim, S. J., Halverson, A. L., & Talamonti, M. (2007) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2006.09.030 · Cited by 60
Molecular targeted treatment and radiation therapy for rectal cancer
Marquardt, F., Rödel, F., Capalbo, G., Weiß, C., & Rödel, C. M. (2009) · Strahlentherapie und Onkologie · doi:10.1007/s00066-009-1936-5 · Cited by 53
Self-citationMoussata, D., Amara, S., Siddeek, B., Decaussin‐Petrucci, M., Hehlgans, S., Paul, R., Mornex, F., Gérard, J., Romestaing, P., Rödel, F., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.06.029 · Cited by 48
Rectal cancer: state of the art in 2012
Rödel, C. M., Hofheinz, R., & Liersch, T. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328352ea02 · Cited by 47
Self-citationHehlgans, S., Petraki, C., Reichert, S., Cordes, N., Rödel, C. M., & Rödel, F. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.006 · Cited by 36
Self-citationThe role of targeted agents in preoperative chemoradiation for rectal cancer
Wadlow, R. C., & Ryan, D. P. (2010) · Cancer · doi:10.1002/cncr.25155 · Cited by 32
Goethals, L., Haustermans, K. M., Perneel, C., Bussels, B., D’Hoore, A., Geboes, K., Ectors, N., Cutsem, E. V., den Bogaert, W. V., & PENNINCKX, F. M. (2005) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2005.03.011 · Cited by 5
Long-Term Follow-Up of a Paradigm-Changing Study: The Paradigm Still Holds
Mamon, H. J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.8863 · Cited by 4
Petersen, C. (2013) · Strahlentherapie und Onkologie · doi:10.1007/s00066-013-0424-0 · Cited by 3
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Engstrom, P. F., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0061 · Cited by 944
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Azad, N., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Garrido-Laguna, I., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0051 · Cited by 827
Rödel, C., Graeven, U., Fietkau, R., Hohenberger, W., Hothorn, T., Arnold, D., Hofheinz, R.-D., Ghadimi, M., Wolff, H. A., Lang-Welzenbach, M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00159-x · Cited by 726
Self-citationDossa, F., Chesney, T. R., Acuna, S. A., & Baxter, N. N. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30074-2 · Cited by 621
Metadata
- Authors
- Fokas, E., Liersch, T., Fietkau, R., Hohenberger, W., Beissbarth, T., Hess, C., Becker, H., Ghadimi, M., Mrak, K., Merkel, S., Raab, H.-R., Sauer, R., Wittekind, C., & Rödel, C.
- Venue
- Journal of Clinical Oncology
- Published
- 2014-05-20
- Volume
- 32
- Issue
- 15
- Pages
- 1554-1562
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2125373402
- Cited by
- 454
- References
- 48
- FWCI
- 16.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.